Abstract
We demonstrate the feasibility of fluorescence imaging of deeply seated tumors using mice injected with an angiogenesis tracer, a vascular endothelial growth factor conjugated with the infrared dye cyanine 7 (VEGF∕Cy7). Our optical-only imaging reconstruction method separately estimates the target depth, and then applies this information to reconstruct functional information such as fluorophore concentration. Fluorescence targets with concentrations as low as sub-25 nM are well reconstructed at depths up to 2 cm in both homogeneous and heterogeneous media with this technique.
Keywords: fluorescence tomography, near-infrared imaging, vascular endothelial growth factor
Introduction
Near-infrared fluorescence diffuse optical tomography (FDOT) has been the subject of intense interest for probing molecular beacons associated with tumor proliferation, growth, and metastasis.1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 FDOT has been successfully demonstrated for imaging tissue phantoms,2, 5, 12, 13 molecular probes in small animals,6, 8, 10, 11 and exogenous contrast agents in human brain7 and breast.9 However, it has been a technical challenge for FDOT to localize deeply seated tumors and to accurately reconstruct low fluorophore concentrations because of the intense light scattering and strong background fluorescence in biological tissue.12, 13, 15, 16 Several techniques have been developed to localize deeply seated fluorophores by using guidance from other imaging modalities such as diffuse optical tomography13, 16, 17, 18 and magnetic resonance imaging (MRI)19 to improve target localization and fluorophore quantification.
Unlike multimodality imaging approaches, we have introduced an optical-only imaging reconstruction method that separately estimates the target structural parameters such as target center (depth and spatial x and y locations) and size, and also reconstructs the functional properties such as fluorophore concentration. The principle of the technique is that the amplitude ratio and phase difference of measured fluorescence signals excited by a single source and received by any two detectors are found to be independent of, or weakly dependent on, fluorophore concentration and lifetime.20 Therefore, the amplitude ratio and phase difference measured from multiple source-detector pairs can be used to estimate the target structural information. With the available target structural information, a dual-zone mesh technique, previously developed by our group for optical absorption and scattering imaging,21, 22, 23 can be employed to reconstruct fluorophore concentration. By separating the imaging procedure into two steps, both the structural and functional parameters can be accurately recovered.20 In this work, we extend the technique to image deeply seated intact animal tumors injected with vascular endothelial growth factor conjugated with the near-infrared dye cyanine 7 (VEGF∕Cy7) and fluorescence phantoms of Cy7 with concentrations as low as 25 nM. Our initial results demonstrate that it is feasible to use this technique for probing deeply seated small tumors in breast.
In the current understanding of cancer progression mechanisms, tumors stimulate excessive development of their own vasculature through a process known as angiogenesis. Active angiogenesis within tumors has been shown to promote tumor progression and facilitate invasion and metastasis to distant sites. A major contributor to tumor angiogenesis is the overproduction of a signaling protein, vascular endothelial growth factor (VEGF), which enhances angiogenesis. VEGF itself is expressed in nearly all solid tumors arising from the breast,24 colon, ovary, and prostate, and thus is a potential target for tumor diagnosis and therapy. VEGF binds to, and is internalized by, receptor proteins (VEGFR) on the membranes of endothelial cells, triggering growth of new vessels to meet increasing metabolic demands. VEGF conjugates with different organic dyes, and radionuclides have been studied by different groups for imaging and monitoring of tumor treatment.25, 26, 27, 28, 29, 30 Our study is motivated by the potential for noninvasive breast imaging of molecular VEGF markers for early breast cancer detection using a novel scVEGF∕Cy tracer, a single-chain (sc) VEGF26 site-specific derivative conjugated with Cy5.5 near-infrared fluorescent dye.
Materials and Methods
Imaging System
We have constructed a 140-MHz frequency-domain system to study the fluorescence properties of VEGF∕Cy7. The excitation source consists of a pigtailed 690-nm laser diode (Thorlabs Incorporated, Newton, New Jersey) sequentially delivered to nine multimode fibers distributed on a hand-held probe (see Fig. 1) using a 1×9 optical switch (Piezosystem, Jena, Germany). The optical probe surface was painted black to make an absorption boundary with an effective reflection coefficient approximately equal to zero.31 The laser output at the optical probe was 18 mW. 14 fiber bundles (Fiber Instrument Sales Incorporated, Oriskany, New York), each 3 mm in diameter and distributed throughout the probe, sequentially collected the fluorescence and excitation light with an optical bandpass filter placed in and out of the light path, respectively. A shared detection assembly sampled received photons at each fiber bundle location. The assembly consisted of a sealed photomultiplier tube (model number R928, Hamamatsu, Bridgewater, New Jersey) plus associated optics that was linearly translated across the array of fiber bundle tips with a stepper motor (Applied Motion Products, Watsonville, California). Details of the assembly, denoted at the collimation system and filter (CSF) in Fig. 1, are shown in Fig. 2a. The experimental time for collection of one set of data from nine source locations and 14 detection locations was approximately 3 min. A sketch of the optical probe is shown in Fig. 2b, where the smaller filled circles are sources and the larger filled circles are the fiber bundle detectors. Only source-detector pairs with separations greater than 1.2 cm were used for the image reconstruction process, enabling use of a diffusion approximation model.
To maximize sensitivity and imaging depth, the design of the detection optics must ensure that the residual excitation and stray light produce responses that are at or below the system electronic and detector noise floors. Different optical designs have been reported to achieve high signal-to-noise ratios.32, 33, 34 Hwang et al.32 reviewed approaches for efficient collection of fluorescence signals in phantom and animal studies. Several optical filter designs were employed to achieve high optical densities for collection of weak fluorescent signals. Our system employed several measures to achieve rejection of nonfluorescent signals in excess of 70 dB. First, the photomultiplier tube (PMT) aperture was restricted to match the incident focused light beam, and all detection optics were mounted in black lens tubes (Thorlabs Incorporated, Newton, New Jersey) encased within a light-sealed flat-black enclosure with the fiber bundles. Second, for fluorescence measurements, a dual-stage interference filter integrated on a single substrate (model number HQ800∕60 M, Chroma Technologies, Rockingham, Vermont) removed excitation and stray light. The broadband filter was designed for greater than 100 dB isolation at 690 wavelength (spectrophotometer-limited measurement of better than 70 dB), and all other optics were antireflection-coated to prevent spurious reflections that could affect the rejection efficiency.
Strict control of the collimation of the incident light on the excitation filters to within +∕−5 deg is critical for rejection performance. Because the large 3-mm detector fiber bundles used to improve light collection efficiency increase beam divergence, near-infrared achromatic lenses with long focal lengths of 30 and 35 mm (AC254-035-B and AC254-030-B, Thorlabs, Newton, New Jersey) were used to achieve the required degree of collimation. The effectiveness of the optical rejection was verified by temporary addition of an absorptive filter that did not change the noise floor of the system over the full range of PMT bias voltages. The combination of high collection efficiency fiber bundles and low-loss, high-rejection optics enabled high sensitivity detection of sub-25-nM fluorescent targets to depths of two centimeters.
Phantom Preparation
Phantom studies were performed to validate our approach. In these experiments, a 0.6% Intralipid solution (Fresenius Kabi, Uppsala, Sweden) infused with 2 nM of Cy7 fluorescent dye (GE Healthcare, Waukesha, Wisconsin) was used to emulate a semi-infinite turbid background medium. The background medium yielded calibrated optical properties of absorption coefficient μa=0.013 cm−1 and reduced scattering coefficient at the excitation wavelength (690 nm), and μa=0.019 cm−1 and at the emission wavelength (776 nm) (see Table 1). Calibration of source strengths and detector gains as well as the Intralipid optical properties was performed by using a least-squares fitting procedure.21 Briefly, in this calibration the excitation power of different source positions, gains of different detector positions, and the slopes of amplitude and phase measurements versus source-detector separations were estimated by fitting the measured data using a semi-infinite diffusion model with an absorption boundary condition.21 The background absorption and reduced scattering coefficients were readily obtained from the estimated slopes of amplitude and phase measurements.
Table 1.
μa,690 | μa,776 | ε690 | ε776 | ||
---|---|---|---|---|---|
0.013 cm−1 | 0.019 cm−1 | 6.5 cm−1 | 5.25 cm−1 | 0.20∕3.07 | 0.20∕2.85 |
The spectral dependence of the Cy7 extinction coefficient was measured by an 8453 UV-visible diode array spectrometer (Hewlett-Packard, Waldbronn, Germany) and values are listed in Table 1. The targets consisted of transparent cylindrical glass tubes of 1.0 cm diameter and 0.6 cm height (volume, πr2h, 0.47 cm3) filled with 0.6% Intralipid and Cy7 concentrations of 10 to 100 nM. The tubes were submerged one by one in the Intralipid background solution as depicted in Fig. 1. An adjustable micrometer stage was used to control the depth of the target. For phantoms and tumors, the center location of the target was aligned with the center of the probe, which was also the position of the central source of the probe shown in Fig. 2b. The lateral alignment was performed by adjusting the target position to intercept the laser output from the central source position while viewing the target with a hand-held mirror held at 45 deg to the probe prior to Intralipid submersion. The spot size of the laser beam was 4 mm at the measured target depths. Through this process, the depth of the target was precisely controlled and the x and y positions were controlled to within 2 mm as determined by the divergence of the beam at the measured depths. Our dual-zone mesh imaging algorithm, used for accurately reconstructing fluorophore concentration, is discussed in Sec. 3B.
Mouse Tumors
SCID∕Ncr (Balb∕c background) mice were injected with 5 million MDA231luc cells26 at the mammary fat pad, and tumors grew to approximately 1 cm size in a few weeks. Tumor-bearing mice were injected intravenously via the retro-orbital sinus with scVEGF∕Cy7 conjugate (injection dose is listed in Table 2), which was allowed to circulate for one hour prior to sacrificing for imaging experiments. The scVEGF∕Cy7, characterized by a fluorescence peak at 776 nm, was prepared by conjugating the derivative of a single-chain (sc) VEGF with Cy7 as described for scVEGF∕Cy5.5 in Ref. 26. Animal protocol was approved by the Institutional Animal Care and Use Committee of University of Connecticut. During the experiment, the euthanized mouse was placed on a thin glass plate, head-to-tail along the y axis, with the mammary fat pad facing the imaging probe, as shown in Fig. 1. The mouse and the plate were submerged in the intralipid and imaged using the same procedures as in the phantom experiments.
Table 2.
Mouse | Injected amount | Concentration |
---|---|---|
1 | 0.1 ml | 19 μM |
2 | 0.1 ml | 16 μM |
Because of the requirement for a matching medium for diffuse optical imaging and the slower data acquisition speed of our system, the mice were euthanized before imaging to avoid unnecessary pressure to live animals. Backer et al.26 reported that the near-infrared fluorescence images persist for several hours after scVEGF∕Cy injection and remain nearly constant for at least 7 days. This is because the Cy5.5 dye remains inside the cell long after the protein is digested. scVEGF-based tracers are internalized by endothelial cells via VEGFR-2 (vascular endothelial growth factor receptor-2)-mediated endocytosis.26 Because of internalization, Cy5.5 fluorescence can be detected in tumor cryosections and in harvested tumors.26 Thus our fluorescence measurements made immediately after euthanization should closely represent what would be anticipated under in-vivo conditions.
Theoretical Analysis
Structural Parameters Estimation
Earlier, we demonstrated a novel technique for simultaneous estimation of target structural parameters and image reconstruction of fluorophore concentration.20 A brief description of the theory is given here for the sake of completeness. The fluorescence fluence excited by a point source located at rS and detected by a point-like detector located at rd can be expressed as35:
(1) |
where r is a spatial variable and Ω represents the target region where the fluorophore is located. S0 is the source strength, and D is the diffusion coefficient. Subscripts “ex” and “fl” indicate that the variables are measured at the excitation and emission wavelengths, respectively. The quantities Λ, τ, and ε are the quantum yield, lifetime, and extinction coefficient of the fluorophore, respectively. G is the appropriate Green’s function, ω is the modulation frequency, and N(r) is the fluorophore concentration. Note that in our imaging setup, the diameter of the source fibers was 62.5 μm and the diameter of the detection fibers was 3 mm. Only source and detector pairs that were separated by at least 1.2 cm were used for structural parameter calculations and image reconstruction. Therefore, the point-like source and detector assumption used in analysis is a valid approximation for our experiments.
The ratio of the fluorescence fluences excited by a source at rs and detected by two detectors at rd1 and rd2 can be obtained as:
(2) |
From Eq. 2 we can see that the only difference between the numerator and the denominator is the term Gfl, which depends on the positions of the two different detectors and position of the target. This observation was validated by simulations and phantom experiments as reported in Ref. 20. For convenience, we define two variables to describe the ratio of the fluorescence fluences: the amplitude of the ratio R and the phase of the ratio ΔΨ, which can be written as:
(3) |
(4) |
Both parameters are functions of the target depth (Z) and size.35 For the low contrast targets, the weak fluorescence signal from the target is embedded with the background signals. Difficulties have been faced to extract the useful target structural parameters from the total fluorescence signal, which is the summation of the background and target fluorescence signals. In our data processing for phantoms, the measured background signal was subtracted from the total signal, and the real and imaginary parts of the subtracted signal were used for amplitude and phase calculation. For the mouse experiments where background signal subtraction was not feasible, we used longer separated source-detector pairs (nearly 1.5 cm) as per the observations in Ref. 20. After the background signals were subtracted from the target signal and∕or the closer source-detector pair contributions were removed, the amplitude and phase were calculated for each measurement. The phase for a measurement is given by
(5) |
A small constant number ζ of about 0.003 was added to the denominator (real part of fluorescence fluency) of Eq. 5 to improve the robustness of phase calculation in the presence of noise. This empirical approach is often used in signal processing to condition the weak signals, and it is very similar in concept to a regulation approach for conditioning an ill-conditioned matrix by adding a small empirical number to the diagonal of the matrix. The new equation for phase (Ψ) is given as:
(6) |
After the amplitudes and phases were calculated for each source-detector pair, the ratios of amplitudes and phases for all pairs of measurements were taken for structural parameter calculations.
Using an extrapolated boundary condition with a semi-infinite geometry, the amplitude and phase of the fluorescence photon density wave for a known target at any position can be generated analytically.31 Therefore, the amplitude ratio (R) and phase difference ΔΨ at any two positions can be calculated.35, 36 When multiple sources and detectors are present, different combinations of any two detectors for a given source can be selected to obtain the ratios of fluorescence fluences. Because our optical probe consists of nine sources and 14 detectors, for each source a total of 91 phase differences and 91 amplitude ratios can be obtained. Thus a total of 1638 (91×2×9) measurements can be taken to determine the structural parameters, which is an overdetermined problem because we have a total of 252 ((9×14×2): 126 amplitudes and 126 phases) measurements. Multiple ratios, analytically obtained, from a known target with known fluorophore concentration and known target structural parameters (location and size) were fitted to the multiple ratios of the measured experimental data from a target with unknown structural parameters (location and size). A chi-square (χ2) fitting technique was used to calculate the error between the analytically generated data and the experimentally measured data. The simplex downhill optimization36, 37 method was used for error minimization by varying the unknown target structural parameters. The final target structural parameters were obtained when the algorithm converged with error less than a certain limit.
Functional Parameter and Image Reconstruction
To reconstruct absorption and∕or fluorescence images, a normalized Born approximation has been widely used.2, 38, 39 This normalization eliminates unknown system parameters, i.e., source strengths, gains of different detectors, background optical properties of the tissue, coupling efficiency to the tissue, etc. In our earlier paper,20 we normalized the target fluorescence measurement with the background fluorescence data for image reconstruction. This normalization method works well only for targets embedded in a homogeneous medium of high target-to-background contrast. For targets embedded in both homogeneous and heterogeneous media, normalization of the fluorescence measurement with the excitation data has been shown to work well,38, 39 because this procedure minimizes the background scattering and absorption, and reconstructs the intrinsic fluorophore concentration of the target. This normalized Born ratio is adopted in this study and is given as:
(7) |
where ϕnB is the normalized Born ratio, ϕfl is the fluorescence measurement at 776 nm after subtraction of the system noise measurement without any fluorophores or targets in the background medium, and ϕexc is the excitation measurement at 690 nm.
For inversion, a dual-zone mesh method was used to reconstruct the fluorophore concentrations. Because the target center is available from the structural parameters, we divide the imaging region into two parts, the background (B) and target (L) region.20 We then discretized the target region of imaging volume 2.5×2.5×1.0 cm into a finer grid (0.1×0.1×0.5 cm), and the background region of volume 6.0×6.0×4.0 cm into a coarser grid (1.0×1.0×0.5 cm). Equation 7 can be expressed as a matrix equation when multiple measurements are available:
(8) |
where M is the normalized Born ratio and corresponds to the value on the left-hand side of Eq. 7. WL and WB are the weight matrices for the target region and background region, respectively. WL has dimension of T×NL and WB has dimension of T×NB. T is the total number of measurements. NL and NB are the total number of voxels in the target region and the background region, respectively (N=NL+NB). [XL] and [XB] are the vector representations of the distribution of total fluorophore concentrations in the target and background regions, respectively. By using this dual-zone mesh, the total number of voxels with unknown concentration can be comparable to the total number of measurements, so that the inverse problem is less underdetermined. Only three iterations were needed for reconstruction to converge to a stable solution. In addition, because the target fluorophore concentration is generally higher than that of the background, the total fluorophore quantity in the target over a smaller voxel is similar to that of the background in a larger voxel, so that Eq. 8 is appropriately scaled for inversion. The distribution of fluorophore concentrations in target and background regions was recovered at the end by dividing the total fluorophore quantity by the appropriate voxel sizes. Because the voxel size of the coarse mesh is 100 times larger than that of the fine mesh, background artifacts are suppressed. Thus the dual-zone mesh approach significantly improves the fluorophore quantification and target-to-background contrast. The total least-squares method and the conjugate gradient technique were used to iteratively solve Eq. 8.20, 21, 22, 23
Depth (z-axis) estimations of the target position were found to be accurate to within 10%. The estimates of x and y coordinates, however, had larger errors that increased with the depth of the target. The typical deviations of the x and y positions from the expected positions were 0.02 to 1.25 cm in both directions with 0.2-cm experimental uncertainty due to the laser beam size at the measured depths (Sec. 2B). In our calculations, the targets were assumed to be spherical targets and the radii of the reconstructed targets ranged from 10 to 50% of the true target size.20 The errors in the location estimations were lower for cylindrical Cy7 tube phantoms and higher for mouse tumors. Because of the x- and y-location uncertainties of up to 1.25 cm, the fine-mesh target volume in the reconstructions was fixed to 2.5×2.5×1.0 cm.
Our dual-zone mesh method is robust to structure estimation errors in x and y dimensions but sensitive to depth.22, 23, 40 If a target was reconstructed at an inaccurate depth, the fluorophore concentration would be either under-reconstructed or over-reconstructed. Because the structural estimation algorithm introduced in Ref. 20 and validated in this work is accurate in estimating depth, the approach provides sufficient accuracy for use with the dual-zone mesh method for imaging reconstruction.
Results
Phantom Studies
An example of a fluorescence image of a 50-nM Cy7 target of diameter 1.0 cm and height 0.6 cm in a 2-nM Cy7 background and 0.6% Intralipid medium is shown in Fig. 3. The Born normalization we used here eliminates the unknown-background optical properties, so the particular background medium does not affect the image reconstruction. From the structural parameter calculation, it was found that the target was located at 1.6 cm depth (z axis). Because the target size estimate was not accurate (an error of 25% in this particular case) image reconstruction was performed over the entire volume with a finer mesh at 1.6 cm depth and a coarse mesh at all other depths. In Fig. 3, the first depth slice is reconstructed at 0.6 cm from the probe surface and the last slice is at 3.6 cm. The spatial dimensions of each slice are 6×6 cm, corresponding to the probe size used. The thickness of each slice corresponds to 0.5 cm in depth. The fluorescence image appeared at the third slice of the fine mesh region (z=1.6 cm). The percentage of the true target fluorophore concentration reconstructed at 1.6 cm depth is 86% (43 nM).
To quantify our approach, one set of experiments was performed for targets with fluorophore concentrations of 10 to 100 nM at different depths (0.5 to 2.0 cm). The target depth was controlled by a micrometer stage, as explained earlier. We estimated the target depth from the chi-square fitting technique as shown in Fig. 4, and the estimated depth was used for fluorescence image reconstruction. The x axis shows the experimental depth measured from the micrometer stage, and the y axis shows the depths estimated from fitting. The results demonstrate that the techniques are able to reconstruct target depths with concentrations as low as 50 nM for depths up to 2 cm, and 25 nM at depths up to 1.5 cm. Each measurement at a particular depth for a given target was repeated three times, and the parameters were reconstructed for all the measurements. The reconstructed depths in Fig. 4 are the means of the three measurements with the standard deviations shown as error bars.
The fluorescence images were reconstructed at the estimated depths obtained from chi-square fitting (from Fig. 4). Figure 5 shows the fluorophore concentrations reconstructed at different depths (from Fig. 4) for various target concentrations. The data clearly shows that the techniques were able to reconstruct the concentration of fluorescence targets located at depths up to 2.0 cm for concentrations as low as 25 nM. Although we could not reconstruct the target depth for the 25-nM target at 2.0 cm, we were able to reconstruct the fluorescence image at the 2.0-cm expected experimental depth, and the reconstructed fluorophore concentration was 16 nM (64%). As shown in Fig. 5, the images at 0.5 cm depth are over-reconstructed, and the fluorophore concentration reconstruction decreases with increasing target depth. The maximum difference in reconstructed fluorophore concentrations across different depths for a given target is within ±20%.
To compare the effect of different background media on image reconstruction, one experiment was done with the same cylindrical tube filled with 100-nM Cy7, prepared similarly as mentioned in Sec. 2B, inserted in chicken breast. The size of the chicken breast was bigger than that of our optical probe, and the probe was in direct contact with it without any matching fluid. The chicken breast had calibrated optical properties of absorption coefficient μa=0.025 cm−1 and reduced scattering coefficient at the excitation wavelength (690 nm), and μa=0.022 cm−1 and at the emission wavelength (776 nm). From the structural parameter calculations, the target depth was estimated to be 1.15 cm, and the fluorescence concentration reconstructed at this depth was 92 nM (shown in Fig. 6). In comparison to the Cy7 images in Intralipid background, the background media (Intralipid or chicken breast) did not affect fluorescence image reconstruction.
Imaging with scVEGF∕Cy7 Tracer
To demonstrate the capability of our approach to image deeply seated tumors in realistic samples, tumor-bearing mice were injected with 100 μl of either 16-μM or 19-μM solution of scVEGF∕Cy7 (as shown in Table 2). The molecular specificity of this conjugate, which binds to and is internalized by VEGF receptors expressed in high number on endothelial cells in angiogenic vasculature, facilitates the visualization of tumor angiogenesis. Mice were sacrificed one hour postinjection, placed in Intralipid solution, and imaged. The mice were positioned as shown in Fig. 1.
Figure 7 shows the depth estimation for the mouse tumors translated to different depths from the optical probe by the micrometer stage. We could reliably estimate the tumor depth up to 1.5 cm from the probe surface. For comparison, depth estimates in the phantom experiments were reliable to depths of 2.0 cm for 50-nM Cy7 tubes and to 1.5 cm for 25-nM Cy7 tubes. The fluorescence images were reconstructed at the estimated depths and shown in Figs. 89 for mouse 1 and 2, respectively, where the color bar is in nanomolar scale. Although the structural parameters were not accurately reconstructed at 2.0 cm, we were still able to reconstruct the fluorophore concentration at the 2.0-cm expected experimental depth, similar to the case for the 25-nM Cy7 tube at 2.0 cm depth in the phantom experiments. The fluorophore concentration reconstructed at 2.0 cm was much lower than that reconstructed at other depths. The maximum fluorophore concentrations in tumors reconstructed at different depths are listed in Table 3, with the average values computed within the full width at half maximum (FWHM) given in parentheses. These concentrations are comparable to estimates based on tumor uptake of radio-labeled scVEGF-based probes.26 Typical uptake for such tracers in the tumors is ∼2 to 3% of the injected dose. Injection of 100 μl of either 16-μM or 19-μM solution of scVEGF∕Cy7 (1.6 to 1.9 nM) should therefore lead to accumulation of 32 to 58 pM of tracer in tumors. For a tumor about 1 cm in diameter, this would correspond to a concentration in the 10 to 50-nM range, which is close to the range of reconstructed values shown in Table 3.
Table 3.
Depth | Mouse 1 | Mouse 2 |
---|---|---|
0.5 cm | 40 nM (29 nM) | 30 nM (21 nM) |
1.0 cm | 32 nM (24 nM) | 36 nM (25 nM) |
1.5 cm | 33 nM (21 nM) | 37 nM (27 nM) |
2.0 cm | 28 nM (20 nM) | 22 nM (16 nM) |
By examining the images obtained from mice, we can see that the background artifact level was higher in the first two layers when the target was located in a deeper range as shown in Figs. 8d, 9d. Because the fluorescence signals generated from a deeper target were much weaker than that from a shallower target, the signal-to-background fluorescence ratio was lower in the former case, which resulted in a higher background artifact level in reconstructed images.
Discussions and Summary
The refined all-optical technique, demonstrated through both phantom and small animal experiments, represents a robust method for reconstructing both structural (target depth) and functional parameters. Several factors contribute to the improved accuracy compared to our earlier results. First, the structural parameters are reconstructed after subtracting the background fluorescence signals from the target fluorescence signal. Because we use both the amplitudes and phases from multiple measurements for chi-square fitting, adding a fixed small constant number to the real part of the fluorescence fluence helps condition the fitting for weak fluorescence signals and increases accuracy for structural parameter estimation.
Second, the use of excitation signal normalization rather than the original fluorescent background signal results in more reliable and accurate reconstruction, both qualitatively and quantitatively, when combined with the depth-guided dual-zone mesh algorithm. These improvements enable a two to three-fold reduction in the minimum fluorophore concentration to 25 nM or lower for depths up to 2 cm. This set of imaging conditions is relevant for clinical applications, and thus the technology has a great potential for molecular imaging of angiogenesis markers for early breast cancer detection.
For the phantoms, where the concentrations and quantum yields of the targets are known beforehand, we can calculate the percentage of reconstruction of absolute fluorophore concentration, as shown in Fig. 5. We do not observe a major difference in fluorophore concentration reconstruction when the Cy7-filled tube is embedded in either an Intralipid medium or in chicken breast. For the mice, since Cy7 is the only fluorophore to emit in the wavelength range we study and the quantum yields of Cy7 and Cy7 conjugates are similar,25, 26 we assume the quantum yields are similar both in phantom and mouse tumors. There might be small local variations in quantum yield to affect the reconstruction accuracy, because of the microenvironment of the tumor tissue that causes nonuniform quantum yield distribution. The studies presented here indicate that there is a good correlation between the capabilities for phantom and mouse imaging in terms of fluorophore concentration levels and target depth limits, even though the absolute information for the mice is not known.
The proposed method for recovering structural information is independent of, or weakly dependent on, the fluorophore concentration, but dependent on the target size and location. However, there is a lower limit of fluorophore concentration below which the signal strength is weak and we cannot recover the structural parameters. The structural parameters we aim to recover are the locations (x, y, and depths) of the targets and the size of the targets. The depth of the target is recovered more accurately than the other parameters. For our phantom studies, we cannot image less than 25-nM fluorophore concentrations at depths up to 2.0 cm. For both mouse tumors and 25-nM Cy7 tubes, we cannot estimate target depths at 2.0 cm. Because the target size is not estimated accurately, we use a much larger fine mesh size in x and y dimensions than the target for reconstructing fluorophore concentrations. We also assume the target size in the z direction is about or less than 1 cm, so that only one fine-mesh layer centered at the estimated depth is used with all other layers in depth reconstructed using a coarse mesh size. As a result, the reported results are only pertinent to imaging small fluorescence targets of 1 cm or less.
Further improvements of the technology are possible. Because spatial coordinates of the target as well as the size estimate are not reliable, a larger estimated fine mesh region is used to account for this uncertainty. In contrast, the depth estimation is a very reliable parameter. From our experience of ultrasound-guided diffused wave imaging of human breasts,21, 22, 23, 40 the target depth is the most important parameter for accurate lesion quantification. With the addition of an ultrasound transducer located in the central region, we can obtain target shape as well as its spatial location. The tradeoff is the loss of sensitivity, especially for low contrast fluorescent targets, due to missing sources and detectors in the central region of the probe. Extensive simulations and phantom experiments show that a smaller ultrasound transducer of 1 cm diameter would not cause a significant degradation in FDOT imaging quality. We are planning to develop a hand-held probe with a smaller ultrasound transducer located at the central region of the probe for providing additional information on target shape and x and y positions. With both normal and oblique angle of incidence excitation sources surrounding the ultrasound transducer, light delivery to the central region can be further improved. The advantage of this reported optical-only technology is that the depth estimation does not depend on ultrasound and thus should correlate reliably with the actual fluorophore distributions. The ultrasound may provide better estimates of the size and location than the optical approach. The fluorophore quantification for lesion may therefore be more accurate with the combined method than the pure ultrasound guided approach.
Acknowledgments
We acknowledge the funding support of the DOD Breast Cancer Research Program (W81XWH-04-1-0415), and National Institutes of Health (R01EB002136) and 2R44CA113080 to Backer.
References
- Hawrysz D. J. and Sevick-Muraca E. M., “Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents,” Neoplasia 2(5), 388–417 (2000). 10.1038/sj.neo.7900118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ntziachristos V. and Weissleder R., “Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation,” Opt. Lett. 26, 893–895 (2001). 10.1364/OL.26.000893 [DOI] [PubMed] [Google Scholar]
- Cubeddu R., Comelli D., Andrea C. D., Taroni P., and Valentini G., “Time-resolved fluorescence imaging in biology and medicine,” J. Phys. D 35, R61–R76 (2002). 10.1088/0022-3727/35/9/201 [DOI] [Google Scholar]
- Graves E. E., Ripoll J., Weissleder R., and Ntziachristos V., “A submillimeter resolution fluorescence imaging system for small animal imaging,” Med. Phys. 30(5), 901–911 (2003). 10.1118/1.1568977 [DOI] [PubMed] [Google Scholar]
- Godavarty A., Thompson A. B., Roy R., Gurfinkel M., Eppstein M. J., Zhang C., and Sevick-Muraca E. M., “Diagnostic imaging of breast cancer using fluorescence-enhanced optical tomography: Phantom studies,” J. Biomed. Opt. 9(3), 488–496 (2004). 10.1117/1.1691027 [DOI] [PubMed] [Google Scholar]
- Ntziachristos V., Schellenberger E. A., Ripoll J., Yessayan D., Graves E., Bogdanov A., Josephson L., and Weissleder R., “Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate,” Proc. Natl. Acad. Sci. U.S.A. 101(33), 12294–12299 (2004). 10.1073/pnas.0401137101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisher J. A. N., Civillico E. F., Contreras D., and Yodh A. G., “In vivo fluorescence microscopy of neuronal activity in three dimensions by use of voltage-sensitive dyes,” Opt. Lett. 29, 71–73 (2004). 10.1364/OL.29.000071 [DOI] [PubMed] [Google Scholar]
- Patwardhan S. V., Bloch S., Achilefu S., and Culver J., “Time-dependent whole-body fluorescence tomography of probe bio-distributions in mice,” Opt. Express 13(7), 2564–2577 (2005). 10.1364/OPEX.13.002564 [DOI] [PubMed] [Google Scholar]
- Corlu A., Choe R., Durduran T., Rosen M. A., Shweiger M., Arridge S. R., Schnall M. D., and Yodh A. J., “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Opt. Express 15(11), 6696–6716 (2007). 10.1364/OE.15.006696 [DOI] [PubMed] [Google Scholar]
- Herve L., Koenig A., Da Silva A., Berger M., Boutet J., Dinten J. M., Peltie P., and Rizo P., “Noncontact fluorescence diffuse optical tomography of heterogeneous media,” Appl. Opt. 46(22), 4896–4906 (2007). 10.1364/AO.46.004896 [DOI] [PubMed] [Google Scholar]
- Kumar A. T., Raymond S. B., Dunn A. K., Bacskai B. J., and Boas D. A., “A time domain fluorescence tomography system for small animal imaging,” IEEE Trans. Med. Imaging 27(8), 1152–1163 (2008). 10.1109/TMI.2008.918341 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ge J., Zhu B., Regalado S., and Godavarty A., “Three-dimensional fluorescence-enhanced optical tomography using a hand-held probe based imaging system,” Med. Phys. 35(7), 3354–3363 (2008). 10.1118/1.2940603 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tan Y. and Jiang H., “Diffuse optical tomography guided quantitative fluorescence molecular tomography,” Appl. Opt. 47(12), 2011–2016 (2008). 10.1364/AO.47.002011 [DOI] [PubMed] [Google Scholar]
- Sevick-Muraca E. M. and Rasmussen J. C., “Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine,” J. Biomed. Opt. 13(4), 041303 (2008). 10.1117/1.2953185 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Joshi A., Bangerth W., Hwang K., Rasmussen J., and Sevick-Muraca E. M., “Plane-wave fluorescence tomography with adaptive finite elements,” Opt. Lett. 31(2), 193–195 (2006). 10.1364/OL.31.000193 [DOI] [PubMed] [Google Scholar]
- Mohajerani P., Eftekhar A. A., and Adibi A., “Object localization in the presence of a strong heterogeneous background in fluorescent tomography,” J. Opt. Soc. Am. A 25(6), 1467–1479 (2008). 10.1364/JOSAA.25.001467 [DOI] [PubMed] [Google Scholar]
- Kepshire D. S., Davis S. C., Dehghani H., Paulsen K. D., and Pogue B., “Subsurface diffuse optical tomography can localize absorber and fluorescent objects but recovered image sensitivity is nonlinear with depth,” Appl. Opt. 46(10), 1669–1678 (2007). 10.1364/AO.46.001669 [DOI] [PubMed] [Google Scholar]
- Lin Y., Gao H., Nalcioglu O., and Gulsen G., “Fluorescence diffuse optical tomography with functional and anatomical a priori information: feasibility study,” Phys. Med. Biol. 52(18), 5569–5585 (2007). 10.1088/0031-9155/52/18/007 [DOI] [PubMed] [Google Scholar]
- Davis S. C., Pogue B. W., Springett R., Leussler C., Mazurkewitz P., Tuttle S. B., Gibbs-Strauss S. L., Jiang S. S., Dehghani H., and Paulsen K. D., “Magnetic resonance-coupled fluorescence tomography scanner for molecular imaging of tissue,” Rev. Sci. Instrum. 79(6), 064302 (2008). 10.1063/1.2919131 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yuan B. and Zhu Q., “Separately reconstructing the structural and functional parameters of a fluorescent inclusion embedded in a turbid medium,” Opt. Express 14(16), 7172–7187 (2006). 10.1364/OE.14.007172 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen N., Guo P., Yan S., Piao D., and Zhu Q., “Simultaneous near infrared diffusive light and ultrasound imaging,” Appl. Opt. 40, 6367–6380 (2001). 10.1364/AO.40.006367 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu Q., Chen N. G., and Kurtzman S., “Imaging tumor angiogenesis using combined near infrared diffusive light and ultrasound,” Opt. Lett. 28, 337–339 (2003). 10.1364/OL.28.000337 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu Q., Cronin Q. E., Currier A., Vine H. S., Huang M. M., Chen N. G., and Xu C., “Benign versus malignant breast masses: optical differentiation using US to guide optical imaging reconstruction,” Radiology 237, 57–66 (2005). 10.1148/radiol.2371041236 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adams J., Carder P. J., Downey S., Forbes M. A., MacLennan K., Allgar V., Kaufman S., Hallam S., Bicknell R., Walker J. J., Cairnduff F., Selby P. J., Perren T. J., Lansdown M., and Banks R. E., “Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effect of Tamoxifen,” Cancer Res. 60, 2898–2905 (2000). [PubMed] [Google Scholar]
- Wu Y., Cai W., and Chen X., “Near-infrared fluorescence imaging of tumor integrin αvβ3 expression with Cy7-labeled RGD multimers,” Mol. Imaging Biol. 8, 226–236 (2006). 10.1007/s11307-006-0041-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baker M. V., Levashova Z., Patel V., Jehning B. T., Claffey K., Blankenberg F., and Backer J. M., “Molecular Imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF based probes,” Nat. Med. 13(4), 504–509 (2007). 10.1038/nm1522 [DOI] [PubMed] [Google Scholar]
- Montent X., Figueiredo J. L., Alencar H., Ntziachristos V., Mahmood U., and Weissleder R., “Tomographic fluorescence imaging of tumor vasculature volume in mice,” Radiology 242(3), 751–758 (2007). 10.1148/radiol.2423052065 [DOI] [PubMed] [Google Scholar]
- Cai W., Chen K., Li Z. B., Gambhir S. S., and Chen X., “Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature,” J. Nucl. Med. 48(11), 1862–1870 (2007). 10.2967/jnumed.107.043216 [DOI] [PubMed] [Google Scholar]
- Chen K., Li Z. B., Wang H., Cai W., and Chen X., “Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots,” Eur. J. Nucl. Med. Mol. Imaging 35(12), 2235–2244 (2008). 10.1007/s00259-008-0860-8 [DOI] [PubMed] [Google Scholar]
- Chang S. K., Rizvi I., Solban N., and Hasan T., “In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment,” Clin. Cancer Res. 14(13), 4146–1153 (2008). 10.1158/1078-0432.CCR-07-4536 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haskell R. C., Svaasand L. O., Tsay T., Feng T., McAdams M. S., and Tromberg B. J., “Boundary conditions for the diffusion equation in radiative transfer,” J. Opt. Soc. Am. A 11(10), 2727–2741 (1994). 10.1364/JOSAA.11.002727 [DOI] [PubMed] [Google Scholar]
- Hwang K., Houston J. P., Rasmussen J. C., Joshi A., Ke S., Li C., and Sevick-Muraca E. M., “Improved excitation light rejection enhances small-animal fluorescent optical imaging,” Mol. Imaging 4(3), 194–204 (2005). [DOI] [PubMed] [Google Scholar]
- Hwang K., Pan T., Joshi A., Rasmussen J. C., Bangerth W., and Sevick-Muraca E. M., “Influence of excitation light rejection on forward model mismatch in optical tomography,” Phys. Med. Biol. 51, 5889–5902 (2006). 10.1088/0031-9155/51/22/011 [DOI] [PubMed] [Google Scholar]
- Vizard D. L., and Mclaughlin W. E., “Imaging system using combined dichroic∕high-pass filters,” United States Patent No. 7031, 084 B2 (2006).
- Li X. D., O’Leary M. A., Boas D. A., Chance B., and Yodh A. G., “Fluorescent diffuse photon density waves in homogeneous and heterogeneous turbid media: analytic solutions and applications,” Appl. Opt. 35(19), 3746–3758 (1996). 10.1364/AO.35.003746 [DOI] [PubMed] [Google Scholar]
- Li X. D., Chance B., and Yodh A. G., “Fluorescent heterogeneities in turbid media: Limits for detection characterization, and comparison with absorption,” Appl. Opt. 37(28), 6833–6944 (1998). 10.1364/AO.37.006833 [DOI] [PubMed] [Google Scholar]
- Press W. H., Teukolsky S. A., Vetterling W. T., and Flannery B. P., Numerical Receipes in C, Cambridge Univ. Press, New York: (1992). [Google Scholar]
- Soubret A., Ripoll J., and Ntziachristos V., “Accuracy of fluorescent tomography in the presence of heterogeneities: study of the normalized Born ratio,” IEEE Trans. Image Process. 24(10), 1377–1386 (2005). [DOI] [PubMed] [Google Scholar]
- Schulz R. B., Ripoll J., and Ntziachristos V., “Noncontact optical tomography of turbid media,” Opt. Lett. 28(18), 1701–1703 (2003). 10.1364/OL.28.001701 [DOI] [PubMed] [Google Scholar]
- Zhu Q., Xu C., Guo P. Y., Aguirre A., Yuan B., Huang F., Castilo D., Gamelin J., Tannenbaum S., Kane M., Hedge P., and Kurtzman S., “Optimal probing of optical contrast of breast lesions of different size located at different depths by US localization,” Technol. Cancer Res. Treat. 4, 365–380 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]